#### ![calendar-Icon](/themes/custom/cosmos/patterns/images/calendar-v2.svg)January 12 - 16, 2026 #### San Francisco, USA Novartis is attending the 44th Annual J.P. Morgan Healthcare Conference in San Francisco from 12-16 January 2026. ![Vas Narasimhan on stage at 2026 J.P.Morgan Healthcare Conference](/sites/novartis_com/files/styles/cta_image/public/2026-01/jpm26-vas-on-stage.jpg.webp?itok=1xGVo2rG "Vas Narasimhan on stage at 2026 J.P.Morgan Healthcare Conference") ## Novartis company presentation On Monday January 12, Novartis CEO, Vas Narasinham, gave an extensive and detailed overview of our portfolio and a deep dive into the four Therapeutic Areas. You can learn more by exploring the link to the PDF file below and listening to a live recording of the session. var kPlayer = KalturaPlayer_55615172 || KalturaPlayer; var config = { targetId: "kaltura_player_6a8cf400cf2ea460840856", provider: { widgetId: "1_d2du28p1", partnerId: "2076321", uiConfId: "55615172" }, playback: { autoplay: false, autopause: false, muted: false, loop: false }, sources: { options: {}, startTime: 0 }, disableUserCache: "true", plugins: {}, sources: { options: {}, startTime: 0 }, ui: { showCCButton: false, settings: { showQualityMenu: true, showSpeedMenu: false }, components: { fullscreen: { disableDoubleClick: false } }, uiComponents: [ { presets: ['Playback', 'Live'], area: 'BottomBarRightControls', replaceComponent: 'Fullscreen', get: kPlayer.ui.components.Remove } ] } }; // Check and add plugins only if they exist if (kPlayer.plugins["download"]) { config.plugins.download = { disable: true }; } if (kPlayer.plugins["transcript"]) { config.plugins["playkit-js-transcript"] = { position: "right", // Default: bottom;('left', 'right', 'top', 'bottom') to enable transcript. expandMode: "over", // Default: alongside;('alongside', 'hidden', 'over') expandOnFirstPlay: false, showTime: true, downloadDisabled: false, printDisabled: false, disable: true }; } if (kPlayer.plugins["googleAnalytics"]) { config.plugins.googleTagManager = {}; config.plugins.googleTagManager.customEventsTracking = {}; config.plugins.googleTagManager.containerId = 'GTM-57RJQ5'; config.plugins.googleTagManager.customEventsTracking.custom = []; config.plugins.googleTagManager.customEventsTracking = { preset: { coreEvents: true, UIEvents: false, playlistEvents: false, castEvents: false } }; } // Ensure the global player registry array always exists, regardless of embed type. window.kalturaPlayerVideos = window.kalturaPlayerVideos || []; try { var kalturaPlayer = kPlayer.setup(config); // Add the player to the global array. window.kalturaPlayerVideos.push(kalturaPlayer); // Load the Player for other media. kalturaPlayer.loadMedia({entryId: "1_3co8lo9l"}); } catch (e) { console.error(e.message) } [Download the full presentation (PDF 1.8 MB)](/sites/novartis_com/files/novartis-investor-presentation-jpm-2026-growth-story.pdf "Download the full presentation (PDF 1.8 MB)") ## Highlights of the Novartis Growth Story presentation [ ### Robust Portfolio Robust portfolio provides a strong foundation for growth, diversified across high-growth therapeutic areas and advanced technology platforms (see slide 9) ](https://www.novartis.com//sites/novartis_com/files/novartis-investor-presentation-jpm-2026-growth-story.pdf#page=9) [ ### Growth Expectations\* Expect net sales to grow +5-6% cc CAGR from 2025 to 2030 and core margin to return to 40%+ by 2029 (see slide 11) ](https://www.novartis.com//sites/novartis_com/files/novartis-investor-presentation-jpm-2026-growth-story.pdf#page=11) [ ### Key Takeaways Novartis focused strategy is delivering results (see slide 29) ](https://www.novartis.com/sites/novartis_com/files/novartis-investor-presentation-jpm-2026-growth-story.pdf#page=29) [Download the full presentation (PDF 1.8 MB)](/sites/novartis_com/files/novartis-investor-presentation-jpm-2026-growth-story.pdf "Download the full presentation (PDF 1.8 MB)") ## In the news Explore some highlights of our media coverage from the JPM 2026 conference. ## Vas Narasinham talks to CNBC's Jim Cramer at JPM 2026\* CNBC Mad Money / Jan 13, 2026 ### Novartis eyes more bolt-on acquisitions, CEO says Reuters / Jan 13, 2026 [Read more](https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-eyes-more-bolt-on-acquisitions-ceo-says-2026-01-12/) ### J.P. Morgan: Novartis Inks China Pacts And Remains Keen To Do More Deals Scrip / Jan 13, 2026 (paywall) [Read more](https://insights.citeline.com/scrip/conferences/jp-morgan/jpmorgan-novartis-inks-china-pacts-and-remains-keen-to-do-more-deals-4ZIGRHHL4BGZDPQVIKWBRE6QWI/) ### JPM26: Novartis Doesn't Have a GLP-1. They Don't Miss It In a World Of Me-Toos BioSpace / Jan 13, 2026 [Read more](https://www.biospace.com/business/novartis-doesnt-have-a-glp-1-they-dont-miss-it-in-a-world-of-me-toos) --- ### Partner with Novartis Partner with us to fuel breakthrough innovation and tackle some of healthcare's toughest challenges, together. Visit our Corporate & Business Development partnering site. [Learn more](/partnering "Learn more") [ ![Mother and daughter cuddling on a bed in a kids room](/sites/novartis_com/files/styles/cards_50_50/public/2023-11/mother-daughter-cuddling-on-a-bed-kid-room-banner.jpg.webp?itok=3GjtnFs5 "Mother and daughter cuddling on a bed in a kids room") ### Strategy Learn about the Novartis strategy and explore our core therapeutic areas and technology platforms. ](/about) [ ![Business woman working on her laptop in a bright atmosphere](/sites/novartis_com/files/styles/cards_50_50/public/2024-10/lp-investors-business-woman-with-a-laptop-on-sofa-banner.jpg.webp?itok=GaTvs6CF "Business woman working on her laptop in a bright atmosphere") ### Investor Relations We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value. ](/investors) ## Related links [Pipeline](https://www.novartis.com/research-development/novartis-pipeline "Pipeline") [Leadership](/about/executive-committee "Leadership")